Shreya Mitra - Concepedia

Author

Shreya Mitra

The University of Texas MD Anderson Cancer Center ORCID

Also Known As

Gagea, Mihai, S Mitra, S. Mitra, S.K. Mitra, Shreya Mitra

Publications

800

Citations

H-Index

Concepts

All Affiliations

The University of Texas MD Anderson Cancer Center The University of Texas at Austin Duke University

About

Shreya Mitra is an author at The University of Texas MD Anderson Cancer Center specializing in cell biology, medicine, and tumor biology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	6	6	289
2	Cell Biology	6	6	289
3	Natural Sciences	2	2	72
4	Health Sciences	1	1	26
5	Biomolecular Engineering	1	1	47

Shreya Mitra

Publications

610

Citations

H-Index

Page 1

	Year	Citations
Lactate Dehydrogenase B: A Metabolic Marker of Response to Neoadjuvant Chemotherapy in Breast Cancer Jennifer B. Dennison, Jennifer R. Molina, Shreya Mitra, Clinical Cancer Research	2013	115
Naturally Occurring Neomorphic PIK3R1 Mutations Activate the MAPK Pathway, Dictating Therapeutic Response to MAPK Pathway Inhibitors Lydia W.T. Cheung, Shuangxing Yu, Dong Zhang, Cancer Cell Signal TransductionMapk Pathway InhibitorsSignaling PathwayReceptor Tyrosine KinaseGenetics	2014	96
Rab25 increases cellular ATP and glycogen stores protecting cancer cells from bioenergetic stress Kwai Wa Cheng, Roshan Agarwal, Shreya Mitra, EMBO Molecular Medicine Reductive StressCellular AtpCell RegulationGlycogen StoresMedicine	2012	78
Stapled peptide inhibitors of RAB25 target context-specific phenotypes in cancer Shreya Mitra, Jeffrey E. Montgomery, Matthew J. Kolar, Nature Communications	2017	50
Jnk2 Effects on Tumor Development, Genetic Instability and Replicative Stress in an Oncogene-Driven Mouse Mammary Tumor Model Peila Chen, Jamye F. O’Neal, Nancy D. Ebelt, PLoS ONE	2010	47
Development of JNK2-Selective Peptide Inhibitors That Inhibit Breast Cancer Cell Migration Tamer S. Kaoud, Shreya Mitra, Sunbae Lee, ACS Chemical Biology Breast OncologyPeptide ScienceTotal JnkTumor BiologyMolecular Pharmacology	2011	47
Rab11-FIP1C Is a Critical Negative Regulator in ErbB2-Mediated Mammary Tumor Progression Pierre-Luc Boulay, Louise Mitchell, Jason Turpin, Cancer Research	2016	41
Rab25 acts as an oncogene in luminal B breast cancer and is causally associated with Snail driven EMT Shreya Mitra, Lorenzo Federico, Wei Zhao, Oncotarget	2016	39
From in Silico Discovery to Intracellular Activity: Targeting JNK–Protein Interactions with Small Molecules Tamer S. Kaoud, Chunli Yan, Shreya Mitra, ACS Medicinal Chemistry Letters	2012	29
c-Jun N-terminal Kinase 2 (JNK2) Enhances Cell Migration through Epidermal Growth Factor Substrate 8 (EPS8) Shreya Mitra, Ju‐Seog Lee, Michael A. Cantrell, Journal of Biological Chemistry Cell ProliferationCancer BiologyCellular PhysiologyTumor BiologySignaling Pathway	2011	26

Page 1